Other

Medici Technologies LLC

Rio Grande Medical Technologies, Inc.

Sandia Corporation

Inlight Solutions, Inc.

Lumidigm, Inc.

The University of New Mexico

Veralight, Inc.

Intel Corporation

Ko Luxembourg Sarl

Robert Philip Eaton

Mark Ries Robinson

Elena Adelle Allen

Robert G Messerschmidt

David M Haaland

Mary K Alam

Edward V Thomas

Robert Kjell Rowe

Michael C Makay

Akifusa Nakazawa

Mark Rohrscheib

Haiping Liao

Fahimeh Salehpour

John D Maynard

Craig Morris Gardner

Cole Derby

Robert D Johnson

Marwood Neal Ediger

Kenneth J Ward

William A Miller

Nanxiang Ge

Elena A Allen

Jonathan J Lee

Johann Ammerlahn

Paul Loftsgard

Petras Avizonis

Bridget L Williams

Robert P Eaton

Geoffrey Mather

Cliona Fleming

Jeffrey Collins

Howland Jones

Erik Andries

Adrey Dolgov

Roxanne N Landesman

Steve L Perella

David Michael Haaland

Kenneth John Ward

Michael Chad Makay

The present invention provides methods and systems that provide for reliable, convenient, and noninvasive assessment of hydration status. The methods and apparatuses can use the temporal sequence of the aortic value opening and closing along with the user's body position to derive parameters that determine the hydration status of the user. The user can use this information to make near-term lifestyle changes that can improve physical performance, health, and general wellbeing.

Hydration assessment system

The systems and methods described herein provide hands free motor control mechanisms based on the natural and inherent movements associated with an activity of interest, and can be combined with gestures or verbal communication based upon pre-defined movements by the participant.

Motor control system based upon movements inherent to self-propulsion

Method and systems are provided for reliable, convenient, self-administered, and cost-effective determination of central venous pressure. The noninvasive method and apparatus use changes in transmural pressure to create detectable changes in peripheral venous vascular volume for the determination of central venous pressure. Transmural pressure changes can be manifested by intravascular or extravascular pressure changes. The system is noninvasive and uses optical measurements of venous volume in the presence of transmural pressure changes. The relationship between the transmural pressure change and the change in vascular venous volume is combined with anatomical measurements to determine the central venous pressure of the subject. Central venous pressure can be used to determine hemodynamic status of the subject to include fluid overload in the heart failure patient.

Methods and apparatuses for central venous pressure measurement status

Embodiments of the present invention provide reliable, convenient, and cost-effective methods and apparatuses to determine the hemodynamic status of the patent. The methods and apparatuses provide for the noninvasive determine of hemodynamic status by using systematic perturbations of venous return or trend observation over time. Embodiments do not require invasive pressure monitoring or the use of ventilator but instead can be an entirely noninvasive system.

Methods and apparatuses for assessment and management of hemodynamic status

Method and systems provide for reliable, convenient, and cost-effective personalized assessment of hemodynamic status in the ambulatory heart failure patient. The method and apparatus use pulse contour analysis of data obtained through observation of the patient for determination of hemodynamic status, and for determination of day-to-day changes in hemodynamic status. Observational assessment of the patient includes monitoring during activities of daily living including sleeping, sitting and standing. These activities create changes in venous return that are used to evaluate cardiac function or changes in cardiac function. The method and system infer body position by using position and motion information obtained by the system. Changes in cardiac function over time or due to changes in body pose are evaluated for the assessment of hemodynamic status, with a focus on changes resulting from fluid overload.

Observational heart failure monitoring system

Technologies for measuring a hydration level of a user includes a hydration measurement device having an arm position sensor and one or more reflectance sensors. The hydration measurement device generates sensor data indicative of a position of a user's arm using the arm position sensor. The hydration measurement device performs reflectance measurements with the reflectance sensor(s) at a first position that is determined based on the sensor data and a second position that is raised relative to the first position that is also based on the sensor data. The hydration measurement device determines a hematocrit of the user's blood based on the reflectance measurements and determines a hydration level of the user based on the determined hematocrit. Other embodiments are described and claimed.

Technologies for measuring hydration level of a user

The systems and methods described herein provide hands free motor control mechanisms based on the natural and inherent movements associated with an activity of interest, and can be combined with gesture communication based upon defined movements by the participant.

One or more processors may be configured to receive, via a radio from one or more sensors, one or more streams of sensor values indicating: (1) accelerations of a boxer's arm within a first range of acceleration, measured by a first acceleration sensor, (2) accelerations of a boxer's arm within a second range of acceleration, measured by a second acceleration sensor, and (3) rotation of the boxer's arm measured by a gyroscope sensor. The one or more processors may be configured to determine, based on the received sensor values from the first acceleration sensor, whether a punch landed but not to measure a force or velocity of the punch. The one or more processors may be configured to determine, based on the received sensor values from the second acceleration sensor, at least one of a force or a velocity of the punch but not to detect whether the punch landed.

Systems and methods for qualitative assessment of sports performance

Example embodiments of the present invention provide methods and apparatuses that enable the detection of bubbles so that hemodynamic performance can be assured following an automated blood analyte measurement. An example apparatus according to the present invention comprises a blood access system, adapted to remove blood from a body and infuse at least a portion of the blood back into the body. The infusion of at least a portion of the blood back in to the body can be done in a manner to assure that no bubbles of clinical significance are injected into the patient. Additionally an example embodiment can assess for the presence of bubbles in the fluid column that can affect hemodynamic monitoring performance. If a condition exists where hemodynamic monitoring performance cannot be assured, an example embodiment can provide appropriate warning or corrective actions.

Detection of bubbles during hemodynamic monitoring when performing automated measurement of blood constituents

Embodiments of the present invention provide an apparatus with a flexible probe suitable for determining properties of in vivo tissue from spectral information collected from various tissue sites. An illumination system provides light at a plurality of broadband ranges, which are communicated to a flexible optical probe. Light homogenizers and mode scramblers can be employed to improve the performance in some embodiments. The optical probe in some embodiments physically contacts the tissue, and in some embodiments does not physically contact the tissue. The optical probe receives light from the illumination system and transmits it to tissue, and receives light diffusely reflected in response to the broadband light, emitted from the in vivo tissue by fluorescence thereof in response to the broadband light, or a combination thereof. The optical probe can communicate the light to a spectrograph which produces a signal representative of the spectral properties of the light. An analysis system determines a property of the in vivo tissue from the spectral properties.

Determination of a measure of a glycation end-product or disease state using a flexible probe to determine tissue fluorescence of various sites

Embodiments of the present invention provide an apparatus suitable for determining properties of in vivo tissue from spectral information collected from various tissue sites. An illumination system provides light at a plurality of broadband ranges, which are communicated to an optical probe. The optical probe can be a flexible probe in some embodiments, allowing ease of application. Light homogenizers and mode scramblers can be employed to improve the performance in some embodiments. The optical probe in some embodiments physically contacts the tissue, and in some embodiments does not physically contact the tissue. The optical probe receives light from the illumination system and transmits it to tissue, and receives light diffusely reflected in response to the broadband light, emitted from the in vivo tissue by fluorescence thereof in response to the broadband light, or a combination thereof. The optical probe can communicate the light to a spectrograph which produces a signal representative of the spectral properties of the light. An analysis system determines a property of the in vivo tissue from the spectral properties.

Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites

Growing community of inventors

Albuquerque, NM, United States of America

Mark Ries Robinson